Question 1

Can I use the Wegovy Savings Card with Medicare?

Accepted Answer

No. Federal insurance programs (Medicare, Medicaid, Tricare, VA, DOD) are explicitly excluded from the Wegovy Savings Card by law. This is true of nearly all manufacturer copay cards.

Medicare Part D already covers Wegovy when prescribed for cardiovascular event risk reduction in eligible patients with established heart disease and either obesity or overweight (FDA-approved indication as of March 2024). For weight loss, the Medicare GLP-1 Bridge began July 1, 2026 and runs through December 31, 2027. It covers Wegovy injection or tablet at $50 per month, but only if you have Part D, you are not already able to get a GLP-1 through your own plan, you do NOT have type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, and you are 18 or older with a BMI of 35+, or 30+ with certain heart failure, hard-to-control high blood pressure or chronic kidney disease, or 27+ with prediabetes or a prior heart attack, stroke or blocked arteries.

Question 2

What is the cheapest way to get Wegovy in 2026?

Accepted Answer

For most people without covered insurance, the cheapest path is the Wegovy pill at $149/month for the 1.5mg dose, which has no published end date. The 4mg dose is $199/month. The 9mg and 25mg doses are $299/month.

For pen users, new patients pay $199/month for the first 2 fills (0.25mg or 0.5mg starter doses), then $349/month for all standard pen doses thereafter.

If your commercial insurance covers Wegovy, the Savings Card at $25/month is the lowest option.

Question 3

What is the difference between Wegovy pill and pen?

Accepted Answer

The Wegovy pill is an oral semaglutide tablet taken once daily, supplied in 1.5mg, 4mg, 9mg and 25mg strengths. The Wegovy pen is taken once weekly by injection.

In clinical trials, the pill produced slightly less weight loss on average than the pen (13.6 percent vs 18.8 percent mean reduction at 64-72 weeks for all patients). But the pill starts lower: $149/month for the 1.5mg dose vs $199/month for a new patient's first 2 pen fills and $349/month for the pen after that.

For patients who prefer oral medication or want the lowest cost path, the pill is now a viable option. Most commercial insurance plans that cover Wegovy cover both formulations.

Question 4

Does Wegovy have a generic coupon?

Accepted Answer

No, and not soon. No generic semaglutide is FDA-approved or marketed in the US. The primary US compound patent, with its patent term extension, runs to 2031, and Novo Nordisk's own FY2025 Form 20-F puts US compound patent expiry for the semaglutide brands at 2032, with method-of-use patents running later still.

Savings therefore come from Novo Nordisk's own programs: the Savings Card if you are commercially insured, or NovoCare Pharmacy Self-Pay if you are not.

Question 5

What if my insurance denies Wegovy coverage?

Accepted Answer

First, appeal. Your prescriber can submit a prior authorization request with clinical justification (BMI, comorbidities such as heart disease or sleep apnea, prior weight-loss attempts). Most commercial plans require prior authorization before covering Wegovy.

If the appeal is denied, your options are: use NovoCare Pharmacy Self-Pay (pill $149-$299/month, pen $199-$349/month), or discuss alternative medications your plan does cover (like Zepbound if that's on your formulary, or a lower-cost non-GLP-1 option like phentermine or Contrave).

Question 6

Can I get compounded semaglutide to save money?

Accepted Answer

As of 2026, the FDA has declared the semaglutide shortage resolved, which means compounding pharmacies are no longer permitted to regularly produce compounded semaglutide injections. Some narrow exceptions exist for documented patient-specific medical needs, but this is no longer a routine cost-saving path.

If a provider is still offering compounded semaglutide in 2026, verify their legal basis carefully. Counterfeit semaglutide is a known safety risk. For cash-paying patients, the Wegovy pill at $149/month is the cheapest legitimate option.

Question 7

Does Medicaid cover Wegovy for weight loss?

Accepted Answer

Coverage varies significantly by state, and many state Medicaid programs exclude Wegovy for weight management. We previously published a count of states covering GLP-1s for obesity; that count came from third-party reporting we did not re-verify on 2026-08-18, so it has been removed rather than repeated.

Medicaid coverage for cardiovascular risk reduction (the second FDA-approved indication) is more common. Check with your state's Medicaid office directly for the most current coverage details.

Wegovy Coupons and Savings (2026 Guide)

Active Wegovy savings in 2026

Want Wegovy savings changes first?

Which Wegovy savings program fits you?

A note on compounded semaglutide

Frequently asked questions

Wegovy Coupons and Savings (2026 Guide)

The Wegovy pill is currently the cheapest Wegovy option at $149/mo

Active Wegovy savings in 2026

Want Wegovy savings changes first?

Which Wegovy savings program fits you?

A note on compounded semaglutide

Frequently asked questions

Related guides

Not sure which Wegovy option is right for you?